Ascribe



Investment Date:February 2009Exit Date:N/A
Investment Type:Public to private management buyout from AIMExit Type:N/A
Sector:Healthcare ITEnterprise Value:£33m

 

Business Description
  • Ascribe is a healthcare business providing IT solutions that make patient data available at 'the point of care'  Its products include  e-prescribing, pharmacy, mental health, patient administration and A&E systems
  • The group is headquartered in Bolton and employs more than 270 staff in the UK, East Africa, Hong Kong, Malaysia, Australia and New Zealand
Investment Rationale
  • A broad range of highly regarded, clinically-focused products that provide real patient benefits at the point of care
  • The business model provides a high level of contracted maintenance and recurring cross-selling revenues
  • Good underlying market growth providing plentiful opportunity for further installations in the UK as well as further penetration of overseas markets
  • An experienced ‘practitioner-led’ management team with a successful track record of both organic growth and sourcing, executing and integrating acquisitions
  • Strong sector knowledge from existing ECI portfolio investments (Clinisys and WCI Group)


 


Back
Valid XHTML 1.0 Transitional Valid CSS! Level Double-A conformance icon, W3C-WAI Web Content Accessibility Guidelines 1.0